CoChat

Effects of Atorvastatin (80 mg) Therapy on Quantity of Epicardial Adipose Tissue in Patients Undergoing Pulmonary Vein Isolation for Atrial Fibrillation

Open access
Soucek, Filip, Covassin, Naima, Singh, Prachi, Ruzek, Lukas, Kara, Tomas, Suleiman, Mahmoud, Lerman, Amir, Koestler, Celeste, Friedman, Paul A., Lopez-Jimenez, Francisco, Somers, Virend K. · 2015 · The American Journal of Cardiology
Cited by 60

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

Epicardial adipose tissue (EAT) has been recognized as a sensitive marker of cardiometabolic risk. Recent evidence suggests efficacy of long-term statin therapy in reducing EAT in patients with coronary artery disease. Whether short-term statin therapy is associated with changes in the volume of EAT is currently unknown. A cohort of atrial fibrillation (AF) patients undergoing pulmonary vein isolation was randomized to receive either 80 mg/day of atorvastatin (n=38, 32 males, age 56 ± 11 years) or placebo (n=41, 33 males, age 56 ± 10 years) for a 3-month period. EAT volume was assessed by cardiac computed tomography at baseline and at follow-up. Patients randomized to statin treatment exhibited a modest but significant decrease in median EAT volume (baseline vs follow-up: 92.3(62.0–133.3) vs 86.9(64.1–124.8) cm3, p < 0.05) while median EAT remained unchanged in the placebo group (81.9(55.5–110.9) vs 81.3(57.1–110.5) cm3, p = NS). Changes in median systemic inflammatory markers and lipid profile were also seen with statin treatment: C-reactive protein (2.4(0.7–3.7) vs 1.1(0.5–2.7) mg/L, p < 0.05), total cholesterol (186(162.5–201) vs 123(99–162.5) mg/dL, p < 0.001), and low density lipoprotein-cholesterol (116(96.5–132.5) vs 56(40.5–81) mg/dL, p < 0.001) diminished, while median body mass index did not change (27.8(25–30) vs 27.6(25.7–30.5) kg/m2, p = NS). No variations occurred in the placebo group. In conclusion, short-term intensive statin therapy significantly reduced the volume of EAT in AF patients.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.amjcard.2015.07.067

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 60

Metadata

Authors
Soucek, F., Covassin, N., Singh, P., Ruzek, L., Kara, T., Suleiman, M., Lerman, A., Koestler, C., Friedman, P. A., Lopez-Jimenez, F., & Somers, V. K.
Venue
The American Journal of Cardiology
Publisher
Elsevier BV
Published
2015-11
Volume
116
Issue
9
Pages
1443-1446
ISSN
0002-9149 (ISSN-L)
OpenAlex
W1738779435
Cited by
60
References
5
FWCI
1.34
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effects of Atorvastatin (80 mg) Therapy on Quantity of Epicardial Adipose Tissue in Patients Undergoing Pulmonary Vein Isolation for Atrial Fibrillation. https://app.cochat.ai/papers/10.1016/j.amjcard.2015.07.067
The paper
Soucek, F., Covassin, N., Singh, P., Ruzek, L., Kara, T., Suleiman, M., Lerman, A., Koestler, C., Friedman, P. A., Lopez-Jimenez, F., & Somers, V. K. (2015). Effects of Atorvastatin (80 mg) Therapy on Quantity of Epicardial Adipose Tissue in Patients Undergoing Pulmonary Vein Isolation for Atrial Fibrillation. The American Journal of Cardiology. https://doi.org/10.1016/j.amjcard.2015.07.067

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.